Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

New CDC director: We can end AIDS epidemic within 7 years

In his first all-staff meeting as director of Centers for Disease Control and Prevention, Robert Redfield, MD, predicted the U.S. could end the AIDS epidemic with tools already available. He also committed the agency’s policies to be rooted in scientific evidence.

AAAHC Announces Winners of the Bernard A. Kershner Innovations in Quality Improvement Award

AAAHC recently honored a primary care center in Arizona and a surgical center in Connecticut for their exemplary work in quality improvement studies. The prestigious Bernard A. Kershner Innovations in Quality Improvement Award recognizes AAAHC-accredited organizations that successfully implemented meaningful changes in their operations to boost quality of care, patient safety and overall efficiency.

Thumbnail

Sutter Health sued by California for alleged anticompetitive practices

California Attorney General Xavier Becerra announced his office has filed an antitrust lawsuit against Sacramento-based Sutter Health, alleging the system used its dominance in Northern California to unlawfully raise prices for services and then used the profits reaped from these practices to grow even larger.

Thumbnail

5 legislative, regulatory priorities for hospitals in 2018 and beyond

The failure to pass funding for reinsurance and cost-sharing reduction subsidies for the Affordable Care Act (ACA) exchanges and the potential for pharmaceutical-backed changes to the 340B drug discount program are just some of the major issues on the American Hospital Association’s radar this year, according to executive vice president of government affairs Tom Nickels.

Thumbnail

Joint Commission CEO: Current quality improvements won’t get hospitals to zero harm

In a presentation at the American College of Healthcare Executives (ACHE) Congress, Joint Commission president and CEO Mark Chassin, MD, MPP, MPH, made the case that creating a high-reliability organization with zero incidents of patient harm shouldn’t be seen as an abstract, aspirational goal.

Thumbnail

WSJ: Walmart in talks to buy Humana

In the latest example of an outside force making a move into healthcare, retail giant Walmart—the largest company in the world by revenue—is reportedly in preliminary discussions to acquire health insurer Humana, according to the Wall Street Journal.

30% of patients have left appointments due to long wait times

If patients end up sitting around for too long, they may just walk out. According to a recent report by Vitals, long wait times led to 30 percent of patients leaving appointments at least once and 20 percent reported changing physicians.

AAMC: Med schools, teaching hospitals generate $562B, 3.1% of GDP

Not far from any policy debate is the oft-repeated fact that healthcare makes up one-sixth of the U.S. economy. Newly published research took a deeper dive to investigate the impact of medical schools and teaching hospitals. And, as one would guess, they contribute a lot of the American economy, accounting for 3.1 percent of gross domestic product.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup